RefluG™ Isorepair is a patented class IIa medical device for the treatment of gastroesophageal reflux symptoms, available for out-licensing under private label. In ready-to-take liquid sachets, it exerts multiple mechanical actions on the esophageal mucosa surface (protective, soothing, lubricant). Its efficacy is proven in a randomized, double-blind placebo-controlled trial.


Gut Health
Study warns prebiotic sodas’ “health halo” may mask limited fiber and gut benefits
A study, presented at the ongoing Nutrition 2026 (July 25–28) flagship annual meeting of the American Society for Nutrition, revealed that prebiotic sodas may contain more sugar and less fiber than marketed on the product...

Gut Health
Tate & Lyle unpacks reformulation beyond sugar reduction for metabolic health
Amid a rise in obesity and overweight prevalence and growing awareness of metabolic health benefits, Tate & Lyle highlights reformulation opportunities for food and beverage manufacturers in fiber fortification, blood sugar...

Gut Health
Fiber demand soars in GLP-1 companion products, synbiotic gummies & precision prebiotics
Fiber no longer belongs solely in the realm of gut health, but has expanded to support diverse claims as ingredient innovation is continually refined. Driven by social media trends like “fibermaxxing,” growing...
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis
Register now

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now

Top Nutrition Trends 2027
Nutrition Insight
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement












